Small renal masses progressing to metastases under active surveillance
Top Cited Papers
Open Access
- 15 July 2011
- Vol. 118 (4), 997-1006
- https://doi.org/10.1002/cncr.26369
Abstract
BACKGROUND: The authors systematically reviewed the literature and conducted a pooled analysis of studies on small renal masses who underwent active surveillance to identify the risk progression and the characteristics associated with metastases. METHODS: A search of the MEDLINE database was performed to identify all clinical series that reported the surveillance of localized renal masses. For studies that reported individual‐level data, clinical and radiographic characteristics of tumors without progression were compared with the characteristics of tumors that progressed to metastases. RESULTS: Eighteen series (880 patients, 936 masses) met screening criteria; and, among these, 18 patients were identified who had tumors that progressed to metastasis (mean, 40.2 months). Six studies (259 patients, 284 masses) provided individual‐level data for pooled analysis. At a mean (±standard deviation) follow‐up of 33.5 ± 22.6 months, the mean initial greatest tumor dimension was 2.3 ± 1.3 cm, and mean linear growth rate was 0.31 ± 0.38 cm per year. Sixty‐five masses (23%) exhibited zero net growth under surveillance, and none of those masses progressed to metastasis. A pooled analysis revealed increased age (age 75.1 ± 9.1 years vs 66.6 ± 12.3 years; P = .03), an initial greatest tumor dimension (4.1 ± 2.1 cm vs 2.3 ± 1.3 cm; P < .0001), initial estimated tumor volume (66.3 ± 100.0 cm3 vs 15.1 ± 60.3 cm3; p = .0001), linear growth rate of (0.8 ± 0.65 cm per year vs 0.3 ± 0.4 cm per year; P = .0001), and a volumetric growth rate of 27.1 ± 24.9 cm3 per year (vs 6.2 ± 27.5 cm3 per year; P < .0001) in the progression cohort. CONCLUSIONS: A substantial proportion of small renal masses remained radiographically static after an initial period of active surveillance. Progression to metastases occurred in a small percentage of patients and generally was a late event. The current results indicated that, in patients who have competing health risks, radiographic surveillance may be an acceptable initial approach, and delayed intervention may be reserved for patients who have tumors that exhibit significant linear or volumetric growth. Cancer 2012;. © 2011 American Cancer Society.This publication has 64 references indexed in Scilit:
- Metastatic Renal Cell Carcinoma Risk According to Tumor SizeJournal of Urology, 2009
- Tumor Size is Associated With Malignant Potential in Renal Cell Carcinoma CasesJournal of Urology, 2009
- Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillanceCancer, 2009
- Partial Nephrectomy Versus Radical Nephrectomy in Patients With Small Renal Tumors—Is There a Difference in Mortality and Cardiovascular Outcomes?Journal of Urology, 2009
- Histopathological Characteristics of Localized Renal Cell Carcinoma Correlate With Tumor Size: A SEER AnalysisJournal of Urology, 2009
- Predicting growth of solid renal masses under active surveillanceUrologic Oncology: Seminars and Original Investigations, 2008
- Renal Masses—To Treat or Not to Treat? If That is the Question are Contemporary Biomarkers the Answer?Journal of Urology, 2008
- Comparison of 1,800 Laparoscopic and Open Partial Nephrectomies for Single Renal TumorsJournal of Urology, 2007
- Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort studyThe Lancet Oncology, 2006
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004